These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Lee F; Bahn DK; Badalament RA; Kumar AB; Klionsky D; Onik GM; Chinn DO; Greene C Urology; 1999 Jul; 54(1):135-40. PubMed ID: 10414740 [TBL] [Abstract][Full Text] [Related]
84. Cryosurgery in benign and malignant diseases of the prostate. Soanes WA; Gonder MJ Int Surg; 1969 Feb; 51(2):104-16. PubMed ID: 5812519 [No Abstract] [Full Text] [Related]
85. Osteitis pubis as a complication of prostate cryotherapy. Seigne JD; Pisters LL; von Eschenbach AC J Urol; 1996 Jul; 156(1):182. PubMed ID: 8648793 [No Abstract] [Full Text] [Related]
86. The speed of ice growth as an important indicator in cryosurgery. Yang WH; Liao ST; Shen SY; Chang HC J Urol; 2004 Jul; 172(1):345-8. PubMed ID: 15201808 [TBL] [Abstract][Full Text] [Related]
88. Serum protein, enzyme and immunoglobulin responses following perineal cryosurgery for carcinoma of the prostate. Milleman LA; Weissman WD; Culp DA J Urol; 1980 May; 123(5):710-11. PubMed ID: 7420561 [TBL] [Abstract][Full Text] [Related]
89. Effects of thermal conductivity and solute concentration on cryosurgery of the prostate. Dow JA; Watherhouse K Int Surg; 1970 Apr; 53(4):251-7. PubMed ID: 5461454 [No Abstract] [Full Text] [Related]
90. Late results following cryosurgery of the prostate (a clinical and panendoscopic study of 80 patients). Kishev SV; Coughlin JD; Dow JA J Urol; 1970 Dec; 104(6):893-7. PubMed ID: 5499834 [No Abstract] [Full Text] [Related]
91. Cryosurgery. 2. The special fields in which cryosurgery is being used. Fraser J; Gill W Nurs Times; 1969 Dec; 65(50):1587-9. PubMed ID: 5364306 [No Abstract] [Full Text] [Related]
94. Editorial: Cryosurgery. Best EJ Dent Dig; 1969 Apr; 75(4):164. PubMed ID: 5251448 [No Abstract] [Full Text] [Related]
95. THE DECLINE IN THE AVERAGE LENGTH OF LIFE. Leary T Science; 1931 Jul; 74(1907):69. PubMed ID: 17739039 [No Abstract] [Full Text] [Related]
96. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Polascik TJ; Nosnik I; Mayes JM; Mouraviev V Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220 [TBL] [Abstract][Full Text] [Related]
97. Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Yang X; Gao M; Xu R; Tao Y; Luo W; Wang B; Zhong W; He L; He Y Front Immunol; 2022; 13():969447. PubMed ID: 36032103 [TBL] [Abstract][Full Text] [Related]
98. Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Rangamuwa K; Leong T; Weeden C; Asselin-Labat ML; Bozinovski S; Christie M; John T; Antippa P; Irving L; Steinfort D Transl Lung Cancer Res; 2021 Jun; 10(6):2842-2857. PubMed ID: 34295682 [TBL] [Abstract][Full Text] [Related]
99. Photosensitizers in prostate cancer therapy. Gheewala T; Skwor T; Munirathinam G Oncotarget; 2017 May; 8(18):30524-30538. PubMed ID: 28430624 [TBL] [Abstract][Full Text] [Related]